These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6655123)

  • 1. Comment on the article 'The influence of urapidil, a new antihypertensive agent, on cerebral perfusion pressure in dogs with and without intracranial hypertension'.
    Willatts SM
    Intensive Care Med; 1983; 9(6):349. PubMed ID: 6655123
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of urapidil, a new antihypertensive agent, on cerebral perfusion pressure in dogs with and without intracranial hypertension.
    Van Aken H; Puchstein C; Anger C; Lawin P
    Intensive Care Med; 1983; 9(3):123-6. PubMed ID: 6863721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of urapidil on intracranial pressure and intracranial compliance in dogs.
    Puchstein C; Van Aken H; Anger C; Hidding J
    Br J Anaesth; 1983 May; 55(5):443-8. PubMed ID: 6849727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of nifedipine and urapidil on autoregulation of cerebral circulation in the presence of an intracranial space occupying lesion].
    Wüsten R; Hemelrijck J; Mattheussen M; Lauwers T; Anger C; Van Aken H
    Anasth Intensivther Notfallmed; 1990 Apr; 25(2):140-5. PubMed ID: 2360708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urapidil-induced increase of the intracranial pressure in head-trauma patients.
    Singbartl G; Metzger G
    Intensive Care Med; 1990; 16(4):272-4. PubMed ID: 2358563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of urapidil on cerebrospinal fluid pressure in humans with uncompromised intracranial compliance.
    Hörmann C; Luz G; Langmayr J; Schalow S; Benzer A
    Intensive Care Med; 1995 Oct; 21(10):853-5. PubMed ID: 8557877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modification of intracranial pressure by urapidil following experimental cold lesions in the cat].
    Seifert V; Hussein S; Stolke D; Friedrich H; Dietz H
    Anasth Intensivther Notfallmed; 1986 Aug; 21(4):218-22. PubMed ID: 3752431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects of the multiple action antihypertensive drug urapidil.
    Mancia G
    Drugs; 1990; 40 Suppl 4():14-20; discussion 28-30. PubMed ID: 2092964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypertensive crises in neurosurgery.
    Puchstein C
    Ann Fr Anesth Reanim; 1989; 8(5):598-602, 558-62. PubMed ID: 2627057
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological activities of the antihypertensive drug urapidil in the rat.
    Verberne AJ; Rand MJ
    Clin Exp Pharmacol Physiol; 1984; 11(4):407-11. PubMed ID: 6097380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure response and renin release following 4 days of treatment with dihydralazine and urapidil in conscious dogs.
    Bacher S; Kraupp O; Beck A; Seitelberger R; Raberger G
    Cardiovasc Res; 1984 Feb; 18(2):67-74. PubMed ID: 6365312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of some hypotensive agents on cerebral circulation].
    Liberman TIu
    Farmakol Toksikol; 1966; 29(2):140-2. PubMed ID: 4386172
    [No Abstract]   [Full Text] [Related]  

  • 13. Preliminary report on cardiovascular responses to urapidil during intubation and extubation.
    Ye T; Luo A; Ren H; Xu J; Gao M
    Chin Med Sci J; 1993 Dec; 8(4):240-2. PubMed ID: 8032072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barbiturates and hyperventilation during intracranial hypertension.
    Louis PT; Goddard-Finegold J; Fishman MA; Griggs JR; Stein F; Laurent JP
    Crit Care Med; 1993 Aug; 21(8):1200-6. PubMed ID: 8339587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic modifications induced by urapidil in man].
    Bielen E; Fagard R; Lijnen P; M'Buyamba-Kabangu JR; Staessen J; Van Hoof R; Amery A
    Therapie; 1990; 45 Suppl 2():191-7. PubMed ID: 2187267
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment modalities for hypertensive patients with intracranial pathology: options and risks.
    Tietjen CS; Hurn PD; Ulatowski JA; Kirsch JR
    Crit Care Med; 1996 Feb; 24(2):311-22. PubMed ID: 8605807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sufentanil decreases cerebral blood flow velocity in patients with elevated intracranial pressure.
    Weinstabl C; Mayer N; Spiss CK
    Eur J Anaesthesiol; 1992 Nov; 9(6):481-4. PubMed ID: 1425617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of reflex tachycardia by central administration of the alpha-1 adrenoceptor antagonists urapidil and prazosin in anesthetized dogs.
    Shebuski RJ; Zimmerman BG
    J Pharmacol Exp Ther; 1985 Aug; 234(2):456-62. PubMed ID: 2862276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of urapidil on blood pressure and volume regulatory hormones during exercise in normal subjects.
    Adnot S; Lotte F; Atlan G
    Drugs; 1990; 40 Suppl 4():52-3. PubMed ID: 2092967
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of reflex tachycardia following alpha-adrenoceptor blockade in conscious dogs: comparison of urapidil with prazosin.
    Shebuski RJ; Zimmerman BG
    J Cardiovasc Pharmacol; 1984; 6(5):788-94. PubMed ID: 6209481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.